Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 694.85M | 767.57M | 561.64M | 631.81M | 685.71M | 726.56M |
Gross Profit | 238.06M | 226.74M | 157.04M | 144.75M | 173.60M | 167.23M |
EBITDA | 106.83M | 113.25M | 81.42M | 70.42M | 212.21M | 89.46M |
Net Income | 73.31M | 64.19M | 45.33M | 30.58M | 113.07M | 30.87M |
Balance Sheet | ||||||
Total Assets | 1.07B | 1.11B | 1.14B | 1.08B | 1.16B | 1.02B |
Cash, Cash Equivalents and Short-Term Investments | 374.27M | 376.39M | 332.39M | 474.98M | 484.97M | 288.33M |
Total Debt | 89.50M | 38.57M | 50.63M | 68.68M | 64.74M | 215.04M |
Total Liabilities | 506.06M | 584.54M | 566.98M | 451.14M | 498.53M | 528.03M |
Stockholders Equity | 535.04M | 505.24M | 453.04M | 433.57M | 446.95M | 342.63M |
Cash Flow | ||||||
Free Cash Flow | 16.09M | 91.31M | 74.00M | 51.21M | 57.81M | 135.49M |
Operating Cash Flow | 21.84M | 96.38M | 76.91M | 54.96M | 61.55M | 147.15M |
Investing Cash Flow | -21.02M | -44.15M | -46.89M | -57.00M | 266.89M | -88.23M |
Financing Cash Flow | -57.33M | -4.60M | -96.97M | -68.73M | -140.86M | -21.05M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $703.75M | 7.26 | 17.60% | 4.22% | 1.78% | 47.73% | |
75 Outperform | S$436.64M | 7.93 | 8.58% | 1.68% | -10.70% | -45.35% | |
71 Outperform | ¥253.62B | 13.00 | 8.49% | 3.09% | 6.31% | 12.77% | |
$9.96B | 13.96 | 20.60% | 5.68% | ― | ― | ||
74 Outperform | S$13.37B | 14.78 | 7.90% | 7.86% | -5.24% | -77.23% | |
74 Outperform | S$677.11M | 14.87 | 11.79% | 8.08% | -1.98% | -29.50% | |
66 Neutral | S$620.93M | 20.27 | 1.03% | 1.71% | -5.00% | -73.03% |
Boustead Singapore’s Real Estate Solutions Division has secured a significant design-and-build contract for a pharmaceutical facility in Tuas Biomedical Park, aimed at enhancing the client’s global network and meeting growing demand for drug discoveries. This contract, along with a previous data center project, increases the division’s order backlog to S$249 million, although it is not expected to materially impact the group’s profitability in the short term.